ZBH

Zimmer Biomet Holdings, Inc.

DOUBTFUL — DATA INCOMPLETEstock

Is ZBH Halal?

Orthopedic medical devices are generally permissible; March 2026 debt is close to the examined 33% asset threshold and gross interest income is not disclosed.

What You Should Know

Zimmer Biomet's March 31, 2026 Form 10-Q reports $22,721.6M of assets, $7,471M of debt, $424.2M of cash, $1,728.6M of receivables and $2,086.7M of quarterly net sales. Debt/assets is 32.88%, liquidity/assets 1.87% and receivables plus cash/assets 9.47%. The medical-device activity is generally permissible, but missing gross interest-income disclosure and the near-threshold debt ratio keep the overall record incomplete.

⚠️ Concerns

  • Debt/assets is 32.88%, close to the examined 33% boundary
  • The filing reports net interest expense but no standalone gross interest-income numerator
  • Orthopedic devices and surgical robotics are generally permissible therapeutic activities
  • Verify the next filing before relying on the result

Current quantitative Sharia screen

Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-13.

USD · millions
Interest-bearing debt / assets
32.88%Within limit
Below 33.333% under FTSE Yasaar

7,471 / 22,721.6

Cash + interest-bearing securities / assets
1.87%Within limit
Below 33.333% under FTSE Yasaar

424.2 / 22,721.6

Receivables + cash / assets
9.47%Within limit
Below 50% under FTSE Yasaar

2,152.8 / 22,721.6

FTSE Yasaar
v4.6, February 2026
Financial
Incomplete
Overall
Incomplete

Debt/assets is 32.88%, liquidity/assets 1.87% and receivables plus cash/assets 9.47%; the FTSE income input is unavailable.

MSCI Islamic (total-assets series)
October 2024 methodology
Financial
Pass
Overall
Incomplete

Debt, liquidity and receivables-plus-cash are below the examined MSCI limits; the business and purification record remains incomplete.

Malaysia SAC financial ratios
single 5% activity benchmark adopted November 2025
Financial
Pass
Overall
Incomplete

Debt and liquidity are below the examined Malaysia SAC limits, but missing gross income disclosure prevents a complete overall result.

Market-cap denominator methods
MSCI M-Series, S&P and Dow Jones methods differ
Financial
Not calculated
Overall
Incomplete

No licensed historical market-cap series is stored.

Business-activity disclosure

Zimmer Biomet designs and sells orthopedic, trauma, extremity, dental and surgical-robotics medical devices. The core therapeutic activity is generally permissible, while product-level financing income and customer use remain qualitative topics.

Limitation: The filing does not provide a single gross interest-income numerator or a universally accepted prohibited-revenue numerator.

Purification

A standalone gross interest-income numerator is not disclosed in the filing, so no fixed purification percentage is asserted.

Inputs, assumptions and primary sources
  • Amounts are USD millions from the unaudited March 31, 2026 Form 10-Q.
  • Debt is the $1,175.9 million current portion plus $6,295.1 million long-term debt.
  • Quarterly net sales are $2,086.7 million; the filing does not present a single gross interest-income numerator.

This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.

🧾
Own ZBH? Purify your portfolio.
Per-holding purification amounts, zakat on your shares, and halal alternatives for flagged holdings — a personalized report prepared for you within 48 hours.
Order Your Report — $49 →
Track ZBH and 30,000+ stocks' live compliance status with Islamicly — 50% off with code ZAKAT50.Get Islamicly →

Want to screen more assets?

Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.

Go to Halal Checker →